Genome editing coming of age for hemoglobinopathy

被引：1

作者：

Jiang, Haiyan ^{[1
]}

机构：

[1] PointLoma Biosci, 4401 Eastgate Mall, San Diego, CA 92121 USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 03期

关键词：

FETAL-HEMOGLOBIN;

D O I：

10.1016/j.ymthe.2023.02.007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：601 / 602

页数：2

共 8 条

[1] Fetal hemoglobin in sickle cell anemia [J].

Akinsheye, Idowu ;

Alsultan, Abdulrahman ;

Solovieff, Nadia ;

Duyen Ngo ;

Baldwin, Clinton T. ;

Sebastiani, Paola ;

Chui, David H. K. ;

Steinberg, Martin H. .

BLOOD, 2011, 118 (01) :19-27

[2]

[Anonymous], 2022, EDIT 301 CLIN TRIAL

[3]

ASH22, ASH22 INTERIM SAFETY

[4] An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level [J].

Bauer, Daniel E. ;

Kamran, Sophia C. ;

Lessard, Samuel ;

Xu, Jian ;

Fujiwara, Yuko ;

Lin, Carrie ;

Shao, Zhen ;

Canver, Matthew C. ;

Smith, Elenoe C. ;

Pinello, Luca ;

Sabo, Peter J. ;

Vierstra, Jeff ;

Voit, Richard A. ;

Yuan, Guo-Cheng ;

Porteus, Matthew H. ;

Stamatoyannopoulos, John A. ;

Lettre, Guillaume ;

Orkin, Stuart H. .

SCIENCE, 2013, 342 (6155) :253-257

[5] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia [J].

Frangoul, H. ;

Altshuler, D. ;

Cappellini, M. D. ;

Chen, Y-S ;

Domm, J. ;

Eustace, B. K. ;

Foell, J. ;

de la Fuente, J. ;

Grupp, S. ;

Handgretinger, R. ;

Ho, T. W. ;

Kattamis, A. ;

Kernytsky, A. ;

Lekstrom-Himes, J. ;

Li, A. M. ;

Locatelli, F. ;

Mapara, M. Y. ;

de Montalembert, M. ;

Rondelli, D. ;

Sharma, A. ;

Sheth, S. ;

Soni, S. ;

Steinberg, M. H. ;

Wall, D. ;

Yen, A. ;

Corbacioglu, S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) :252-260

[6]

ir.crisprtx, ASH 2022 EX CEL

[7] Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A [J].

Sankaran, Vijay G. ;

Menne, Tobias F. ;

Xu, Jian ;

Akie, Thomas E. ;

Lettre, Guillaume ;

Van Handel, Ben ;

Mikkola, Hanna K. A. ;

Hirschhorn, Joel N. ;

Cantor, Alan B. ;

Orkin, Stuart H. .

SCIENCE, 2008, 322 (5909) :1839-1842

[8] Treatment of Individuals with Severe Sickle Cell Disease with OTQ923, an Autologous, Ex Vivo, CRISPR/Cas9-Edited, CD34+Hematopoietic Stem and Progenitor Cell Product, Leads to Durable Engraftment and Fetal Hemoglobin Induction [J].

Sharma, Akshay ;

Boelens, Jaap Jan ;

Cancio, Maria, I ;

Hankins, Jane ;

Bhad, Prafulla A. ;

Lewandowski, Andrew ;

Zhao, Xiaojun ;

Chitnis, Shripad ;

Peddinti, Radhika ;

Zheng, Yan ;

Kapoor, Neena ;

Ciceri, Fabio ;

Yuan, Jianping ;

Yu, Vionnie W. ;

Stevenson, Susan C. ;

De Vita, Serena ;

LaBelle, James .

BLOOD, 2022, 140 :1906-1908

← 1 →